A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.
A synthetic compound, decynium-22, is able to turn off SERT in the brain, enhancing the effectiveness of SSRIs.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
Researchers report administering cannabinoids soon after a traumatic event can prevent PTSD-like symptoms in rats.
Researchers report a single dose of a widely prescribed antidepressant causes quantifiable changes in the brain within a matter of hours.
A new study reports nitrous oxide is showing promise as an effective treatment for depression.
According to a new study, transgenic mice with serotonin deficiencies are more vulnerable to social stressors that their normal litter-mates.
Researchers claim to have identified a new compound that can effectively treat depression in less than 24 hours with minimal side effects.
According to a new study, pregnant women who take SSRI antidepressants have lower risks of certain pregnancy complications. However, there is an increased risk of neonatal problems associated with mothers who take the medications.